Expertise in
2
conditions

Francois Guilhot

Poitiers, FR 
Expertise in
2
conditions
Poitiers, FR 

Overview

Francois Guilhot practices practicing medicine in Poitiers, France.

Mr. Guilhot is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Multiple Myeloma, Thrombocytopenia, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Poitiers, France
Other Locations
Lyon, France
Besancon, France
Bordeaux, France
Nantes, France
Toulouse, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)
Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)
Enrollment Status: Completed
Publish Date: May 26, 2026
Intervention Type: Drug
Study Drug: Nilotinib
Study Phase: Phase 2
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: March 17, 2026
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2
View 1 Less Clinical Trial

95 Total Publications

Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patients.
Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patients.
Journal: Cancer immunology, immunotherapy : CII
Published: September 11, 2025

Frequently Asked Questions about Francois Guilhot

Is Francois Guilhot a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Francois Guilhot is classified as an Distinguished expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Francois Guilhot participate in research or clinical trials?

Yes. Francois Guilhot has published 95 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Francois Guilhot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guilhot's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile